INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings

Most active filers · 30d

  1. 01Kurtz George0B / 239S · 10 late239 trades$59.22M
  2. 02SPSaba Capital Management, L.P.68B / 23S · 14 late91 trades$30.01M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  6. 06SJSheena Jonathan0B / 43S43 trades$3.14M
  7. 07CFCheng Chi Fung0B / 42S42 trades$15.33M
  8. 08RJRubinstein Julie0B / 37S37 trades$6.25M
  9. 09SLSpeiser Michael L0B / 35S35 trades$14.00M
  10. 10RARothblatt Martine A0B / 33S33 trades$5.50M
Data sources
SEC Form 413m ago
House PTR13m ago
SEC 13F12m ago
Robinhood Chain12m ago

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 99 insiders$642K
  4. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  5. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  6. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  7. SELLADUSAddus HomeCare CorpNov 6 – Nov 96 insiders$16.28M
  8. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K

Form 4 transactions

21,973 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
27
CK
Choudary Kiran KumarChief Financial Officer
RBRKRubrik, Inc.
Open-market sale
SELL$213K
2,795 sh
Dec 17, 2025Dec 18, 2025
Page 468 of 550
← PrevNext →
traded Dec 17, 2025
+1d
SEC Form 4

Evidence

26
AN
Agrawal NitinChief Financial Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$63K
882 sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC Form 4

Evidence

26
SM
Saintil MerlineDirector
RKLBRocket Lab Corp
Open-market sale · 10b5-1 plan
SELL$28K
500 sh
Dec 17, 2025Dec 18, 2025
traded Dec 17, 2025
+1dSEC Form 4

Evidence

26
VC
Vanderhook ChristopherDirector, Chief Operating Officer, 10% Owner
DSPViant Technology Inc.
Open-market sale · 10b5-1 plan
SELL$60K
5,000 sh
Dec 18, 2025Dec 18, 2025
traded Dec 18, 2025
+0dSEC Form 4

Evidence

26
VC
Vanderhook ChristopherDirector, Chief Operating Officer, 10% Owner
DSPViant Technology Inc.
Open-market sale · 10b5-1 plan
SELL$59K
5,000 sh
Dec 17, 2025Dec 18, 2025
traded Dec 17, 2025
+1dSEC Form 4

Evidence

26
VT
Vanderhook TimothyDirector, CEO and Chairman, 10% Owner
DSPViant Technology Inc.
Open-market sale · 10b5-1 plan
SELL$59K
5,000 sh
Dec 17, 2025Dec 18, 2025
traded Dec 17, 2025
+1dSEC Form 4

Evidence

26
CV
Capital V LLC10% Owner
DSPViant Technology Inc.
Open-market sale · 10b5-1 plan
SELL$176K
15.0K sh
Dec 17, 2025Dec 18, 2025
traded Dec 17, 2025
+1dSEC Form 4

Evidence

26
SM
Saintil MerlineDirector
RKLBRocket Lab Corp
Open-market sale · 10b5-1 plan
SELL$11K
200 sh
Dec 17, 2025Dec 18, 2025
traded Dec 17, 2025
+1dSEC Form 4

Evidence

26
CV
Capital V LLC10% Owner
DSPViant Technology Inc.
Open-market sale · 10b5-1 plan
SELL$179K
15.0K sh
Dec 18, 2025Dec 18, 2025
traded Dec 18, 2025
+0dSEC Form 4

Evidence

26
VT
Vanderhook TimothyDirector, CEO and Chairman, 10% Owner
DSPViant Technology Inc.
Open-market sale · 10b5-1 plan
SELL$60K
5,000 sh
Dec 18, 2025Dec 18, 2025
traded Dec 18, 2025
+0dSEC Form 4

Evidence

26
CM
Chi MichaelChief Operating Officer
HIMSHims & Hers Health, Inc.
Open-market sale · 10b5-1 plan
SELL$505K
13.8K sh
Dec 17, 2025Dec 18, 2025
traded Dec 17, 2025
+1dSEC Form 4

Evidence

25
LS
Lee Benjamin SeongChief Legal Officer
RDDTReddit, Inc.
Open-market sale · 10b5-1 plan
SELL$926K
4,153 sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC Form 4

Evidence

25
FK
Feeley KevinCHIEF FINANCIAL OFFICER
WGSGeneDx Holdings Corp.
Open-market sale
SELL$51K
366 sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC Form 4

Evidence

25
LS
Lee Benjamin SeongChief Legal Officer
RDDTReddit, Inc.
Open-market sale · 10b5-1 plan
SELL$4.50M
18.8K sh
Dec 18, 2025Dec 18, 2025
traded Dec 18, 2025
+0dSEC Form 4

Evidence

25
A
A-6684 Ltd.10% Owner
TOFBTOFUTTI BRANDS INC
Open-market purchase
BUY$2,503
3,250 sh
Dec 17, 2025Dec 18, 2025
traded Dec 17, 2025
+1dSEC Form 4

Evidence

23
UC
Ugwumba Chidozie10% Owner
CLNNClene Inc.
Open-market sale
SELL$74K
10.9K sh
Dec 11, 2025Dec 18, 2025
traded Dec 11, 2025
+7dSEC Form 4

Evidence

23
UC
Ugwumba Chidozie10% Owner
CLNNClene Inc.
Open-market sale
SELL$69K
10.6K sh
Dec 15, 2025Dec 18, 2025
traded Dec 15, 2025
+3dSEC Form 4

Evidence

23
UC
Ugwumba Chidozie10% Owner
CLNNClene Inc.
Open-market sale
SELL$52K
7,603 sh
Dec 12, 2025Dec 18, 2025
traded Dec 12, 2025
+6dSEC Form 4

Evidence

22
FK
Feeley KevinCHIEF FINANCIAL OFFICER
WGSGeneDx Holdings Corp.
Open-market sale
SELL$31K
215 sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC Form 4

Evidence

22
FK
Feeley KevinCHIEF FINANCIAL OFFICER
WGSGeneDx Holdings Corp.
Open-market sale
SELL$48K
334 sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC Form 4

Evidence

22
FK
Feeley KevinCHIEF FINANCIAL OFFICER
WGSGeneDx Holdings Corp.
Open-market sale
SELL$49K
331 sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC Form 4

Evidence

22
FK
Feeley KevinCHIEF FINANCIAL OFFICER
WGSGeneDx Holdings Corp.
Open-market sale
SELL$3,920
26 sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC Form 4

Evidence

22
FK
Feeley KevinCHIEF FINANCIAL OFFICER
WGSGeneDx Holdings Corp.
Open-market sale
SELL$18K
131 sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC Form 4

Evidence

22
FK
Feeley KevinCHIEF FINANCIAL OFFICER
WGSGeneDx Holdings Corp.
Open-market sale
SELL$14K
97 sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC Form 4

Evidence

22
MR
Markus RichardChief Medical Officer
RCUSArcus Biosciences, Inc.
Open-market sale · 10b5-1 plan
SELL$111K
5,052 sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC Form 4

Evidence

22
TC
Tang Carolyn C.General Counsel
RCUSArcus Biosciences, Inc.
Open-market sale · 10b5-1 plan
SELL$168K
7,658 sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC Form 4

Evidence

22
FK
Feeley KevinCHIEF FINANCIAL OFFICER
WGSGeneDx Holdings Corp.
Open-market sale
SELL$18K
127 sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC Form 4

Evidence

21
CE
Cooper Jeffrey ElliottChief Financial Officer
GWREGuidewire Software, Inc.
Open-market sale · 10b5-1 plan
SELL$552K
2,872 sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC Form 4

Evidence

21
MJ
Morrissey Michael JamesEVP, Head of Tech. Operations
INCYINCYTE CORP
Open-market sale · 10b5-1 plan
SELL$420K
4,323 sh
Dec 17, 2025Dec 18, 2025
traded Dec 17, 2025
+1dSEC Form 4

Evidence

21
LS
Lee Benjamin SeongChief Legal Officer
RDDTReddit, Inc.
Open-market sale · 10b5-1 plan
SELL$569K
2,600 sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC Form 4

Evidence

20
WC
Whitfield Dianne C.Chief Human Resources Officer
TARSTarsus Pharmaceuticals, Inc.
Open-market sale · 10b5-1 plan
SELL$592K
7,397 sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC Form 4

Evidence

18
MJ
Morrissey Michael JamesEVP, Head of Tech. Operations
INCYINCYTE CORP
Open-market sale · 10b5-1 plan
SELL$81K
833 sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC Form 4

Evidence

18
AA
Azoy AlexanderChief Accounting Officer
RCUSArcus Biosciences, Inc.
Open-market sale · 10b5-1 plan
SELL$97K
4,343 sh
Dec 18, 2025Dec 18, 2025
traded Dec 18, 2025
+0dSEC Form 4

Evidence

18
VC
Vanderhook ChristopherDirector, Chief Operating Officer, 10% Owner
DSPViant Technology Inc.
Open-market sale · 10b5-1 plan
SELL$107K
9,102 sh
Dec 17, 2025Dec 18, 2025
traded Dec 17, 2025
+1dSEC Form 4

Evidence

18
LS
Lee Benjamin SeongChief Legal Officer
RDDTReddit, Inc.
Open-market sale · 10b5-1 plan
SELL$232K
1,063 sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC Form 4

Evidence

18
TC
Tang Carolyn C.General Counsel
RCUSArcus Biosciences, Inc.
Open-market sale · 10b5-1 plan
SELL$151K
6,810 sh
Dec 17, 2025Dec 18, 2025
traded Dec 17, 2025
+1dSEC Form 4

Evidence

18
LS
Lee Benjamin SeongChief Legal Officer
RDDTReddit, Inc.
Open-market sale · 10b5-1 plan
SELL$87K
400 sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC Form 4

Evidence

18
MR
Markus RichardChief Medical Officer
RCUSArcus Biosciences, Inc.
Open-market sale · 10b5-1 plan
SELL$100K
4,494 sh
Dec 17, 2025Dec 18, 2025
traded Dec 17, 2025
+1dSEC Form 4

Evidence

18
AA
Azoy AlexanderChief Accounting Officer
RCUSArcus Biosciences, Inc.
Open-market sale · 10b5-1 plan
SELL$52K
2,376 sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC Form 4

Evidence

18
VT
Vanderhook TimothyDirector, CEO and Chairman, 10% Owner
DSPViant Technology Inc.
Open-market sale · 10b5-1 plan
SELL$107K
9,102 sh
Dec 17, 2025Dec 18, 2025
traded Dec 17, 2025
+1dSEC Form 4

Evidence